Analysis of Reagent Lot-to-Lot Comparability Tests in Five Immunoassay Items

被引:0
|
作者
Kim, Hyun Soo [1 ]
Kang, Hee Jung [1 ]
Whang, Dong Hee [2 ]
Lee, Seong Gyu [3 ]
Park, Min Jeong [1 ]
Park, Ji-Young [1 ]
Lee, Kyu Man [1 ]
机构
[1] Hallym Univ, Coll Med, Dept Lab Med, Seoul 150719, South Korea
[2] Inje Univ, Seoul Paik Hosp, Dept Lab Med, Seoul, South Korea
[3] Bundang Jesaeng Gen Hosp, Dept Lab Med, Songnam, South Korea
来源
关键词
Immunoassay; Quality-control; Lot; Reagent;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We investigated the degree of lot-to-lot reagent variation for 5 common immunoassay items. We measured the commercial as well as in-house controls for a-fetoprotein (AFP), ferritin, CA19-9, quantitative hepatitis B surface antigen (HBsAg), and hepatitis B surface antibody (anti-HBs) 10 times each by using both the old and the new lot of reagents whenever a reagent lot was changed, over a period of 10 months. The differences in the mean control values, the percent difference (% difference), and the difference to between-run standard deviation ratio (D:SD ratio) between successive lots were calculated. The % difference in mean control values between 2 reagent lots ranged from 0.1 to 17.5% for AFP, 1.0 to 18.6% for ferritin, 0.6 to 14.3% for CA19-9, 0.6 to 16.2% for HBsAg, and 0.1 to 17.7% for anti-HBs except negative controls of HBsAg and anti-HBs. The maximum D: SD ratios between 2 lots were 4.37 for AFP, 4.39 for ferritin, 2.43 for CA19-9, 1.64 for HBsAg, and 4.16 for anti-HBs. Thus, we have experienced extensive variability in lot-to-lot reagent variation for 5 immunoassay items, indicating that reagent lot-to-lot comparability tests should be continuously performed and that laboratories should determine their own acceptance criteria for each item.
引用
收藏
页码:165 / 173
页数:9
相关论文
共 28 条
  • [1] Access® thyroglobulin reagent lot-to-lot variability
    Mattke, J. M.
    Smith, T.
    Golden, W.
    Kivens, W. J.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A107 - A107
  • [2] Lot-to-lot reagent verification: challenges and possible solutions
    Loh, Tze Ping
    Sandberg, Sverre
    Horvath, Andrea Rita
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (05) : 675 - 680
  • [3] LOT-TO-LOT VARIABILITY OF 2 RHEUMATOID-FACTOR TESTS
    KILBOURN, JP
    JOURNAL OF THE AMERICAN MEDICAL TECHNOLOGISTS, 1977, 39 (05): : 237 - 238
  • [4] USE OF THE REFLOTRON SYSTEM FOR CHOLESTEROL ASSAY IN CAPILLARY BLOOD, VENOUS-BLOOD, AND SERUM EVALUATION OF ACCURACY AND LOT-TO-LOT REAGENT COMPARABILITY
    BOERMA, GJM
    GELDERLAND, J
    VANGORP, I
    LEIJNSE, B
    CLINICAL CHEMISTRY, 1988, 34 (10) : 2117 - 2119
  • [5] Advanced methods for analysis of lot-to-lot yield variation
    Pak, J
    Kittler, R
    Wen, P
    1997 IEEE INTERNATIONAL SYMPOSIUM ON SEMICONDUCTOR MANUFACTURING CONFERENCE PROCEEDINGS, 1997, : E17 - E20
  • [6] Evaluation of the CLSI EP26-A protocol for detection of reagent lot-to-lot differences
    Katzman, Brooke M.
    Ness, Karl M.
    Algeciras-Schimnich, Alicia
    CLINICAL BIOCHEMISTRY, 2017, 50 (13-14) : 768 - 771
  • [7] Centralization of multisite reagent lot-to-lot validation for Ortho Clinical Vitros chemistry instruments
    To, Michelle
    Raizman, Joshua E.
    Goudreau, Bobbi-Lynn
    Higgins, Trefor
    Brun, Miranda
    Tsui, Albert K. Y.
    CLINICAL BIOCHEMISTRY, 2021, 97 : 62 - 66
  • [8] Lot-to-lot analysis of molding compound for PQFP package assembly
    Hongsmatip, T
    TWENTY FIRST IEEE/CPMT INTERNATIONAL ELECTRONICS MANUFACTURING TECHNOLOGY SYMPOSIUM, 1997, : 165 - 171
  • [9] Lot-to-Lot Reproducibility of Standardized Allergen Extracts in IgE In Vitro Diagnostic Tests
    Dinh, Lauren
    Sinson, Edsel
    Nguyen, Steven
    Liao, Cindy
    Rodems, Kelline
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB151 - AB151
  • [10] Lot-to-lot reagent verification: Effect of sample size and replicate measurement on linear regression approaches
    Koh, Norman Wen Xuan
    Markus, Corey
    Loh, Tze Ping
    Lim, Chun Yee
    IFCC Working Grp Method Evaluation Protocols
    CLINICA CHIMICA ACTA, 2022, 534 : 29 - 34